China-developed nasal spray vaccine for coronavirus approved for clinical trialsChristian Fernsby ▼ | September 10, 2020
The University of Hong Kong (HKU) announced that the clinical trials of a nasal spray vaccine for coronavirus jointly developed by the university's Department of Microbiology and mainland institutions have been approved.
Nasal spray University of Hong Kong
It is the first nasal spray COVID-19 vaccine approved by the China's National Medical Products Administration for clinical trial in humans.
The HKU said in a statement that its vaccine strategy has been selected as one of the five vaccine technologies by the Ministry of Science and Technology for further evaluation. ■